Literature DB >> 23670483

Mesenchymal stem cells play an important role in host protective immune responses against malaria by modulating regulatory T cells.

Reva S Thakur1, Sultan Tousif, Vikky Awasthi, Anirban Sanyal, P K Atul, Parveen Punia, Jyoti Das.   

Abstract

Plasmodium spp. parasites, the causative agents of malaria, survive and replicate in human hosts by modulating host protective immune responses. In a rodent model, malaria manifests as a severe splenomegaly, with infiltration of cells and lympho-proliferation as major contributing factors of the immunopathology. However, the cellular contents and the functions of these cells have not been well studied. Here, we report that Plasmodium berghei infection of mice leads to massive recruitment of mesenchymal stem cells (MSCs) in secondary lymphoid organs. Infusion of these cells into naïve mice was able to confer host resistance against malaria. Furthermore, MSCs augmented interleukin (IL)-12 production but suppressed IL-10 production in recipient animals. In addition, we observed dramatic reductions of regulatory T (Treg) cells in animals that received MSCs. Taken together, our findings have identified recruitment of MSCs as a novel host protective mechanism adopted by the host to combat malaria by modulating Treg-cell responses.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Hemozoin; Malaria; Mesenchymal stem cell; Regulatory T cell

Mesh:

Substances:

Year:  2013        PMID: 23670483     DOI: 10.1002/eji.201242882

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

Review 1.  Immunomodulation in stem cell differentiation into neurons and brain repair.

Authors:  Henning Ulrich; Isis Cristina do Nascimento; Jozsef Bocsi; Attila Tárnok
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

2.  Stem cell therapy for the treatment of parasitic infections: is it far away?

Authors:  Yan Zhang; Jing-Yi Mi; Yong-Jun Rui; Yong-Liang Xu; Wei Wang
Journal:  Parasitol Res       Date:  2013-11-26       Impact factor: 2.289

3.  Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria.

Authors:  Mariana C Souza; Johnatas D Silva; Tatiana A Pádua; Natália D Torres; Mariana A Antunes; Debora G Xisto; Thiago P Abreu; Vera L Capelozzi; Marcelo M Morales; Ana A Sá Pinheiro; Celso Caruso-Neves; Maria G Henriques; Patricia R M Rocco
Journal:  Stem Cell Res Ther       Date:  2015-05-22       Impact factor: 6.832

Review 4.  Challenges of drug-resistant malaria.

Authors:  Shweta Sinha; Bikash Medhi; Rakesh Sehgal
Journal:  Parasite       Date:  2014-11-18       Impact factor: 3.000

Review 5.  Unexpected encounter of the parasitic kind.

Authors:  Holly Matthews; Florian Noulin
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

Review 6.  Mesenchymal Stem Cells: A Novel Therapeutic Approach to Enhance Protective Immunomodulation and Erythropoietic Recovery in Malaria.

Authors:  Meenu Kalkal; Mrinalini Tiwari; Reva S Thakur; Vikky Awasthi; Veena Pande; Debprasad Chattopadhyay; Jyoti Das
Journal:  Stem Cell Rev Rep       Date:  2021-06-12       Impact factor: 5.739

Review 7.  Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.

Authors:  Amit Sharma; Anuja Chakraborty; Bithiah Grace Jaganathan
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

8.  Tamoxifen Suppresses the Immune Response to Plasmodium berghei ANKA and Exacerbates Symptomatology.

Authors:  Luis Antonio Cervantes-Candelas; Jesús Aguilar-Castro; Fidel Orlando Buendía-González; Omar Fernández-Rivera; Armando Cervantes-Sandoval; Jorge Morales-Montor; Martha Legorreta-Herrera
Journal:  Pathogens       Date:  2021-06-12

9.  Stem cell therapy: a novel treatment option for cerebral malaria?

Authors:  Wei Wang; Hui Qian; Jun Cao
Journal:  Stem Cell Res Ther       Date:  2015-08-08       Impact factor: 6.832

10.  Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.

Authors:  Tadeu Diniz Ramos; Johnatas Dutra Silva; Alessandra Marcia da Fonseca-Martins; Juliana Elena da Silveira Pratti; Luan Firmino-Cruz; Diogo Maciel-Oliveira; Julio Souza Dos-Santos; João Ivo Nunes Tenorio; Almair Ferreira de Araujo; Célio Geraldo Freire-de-Lima; Bruno Lourenço Diaz; Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco; Herbert Leonel de Matos Guedes
Journal:  Stem Cell Res Ther       Date:  2020-08-31       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.